P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.033
https://www.valueinhealthjournal.com/article/S1098-3015(23)00133-X/fulltext
Title :
P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00133-X&doi=10.1016/j.jval.2023.03.033
First page :
Section Title :
Open access? :
No
Section Order :
11651